Zimmer Biomet Holdings Inc. (ZBH)

The total asset value of Zimmer Biomet Holdings Inc. (ZBH) stood at $ 23,579 Mln as on 31-Mar-23

The share price of Zimmer Biomet Holdings Inc. (ZBH) is $116.13 (NYSE) as of 06-Dec-2023 16:10 EST. Zimmer Biomet Holdings Inc. (ZBH) has given a return of -6.36% in the last 3 years.

Zimmer Biomet Holdings Inc. (ZBH) has a market capitalisation of $ 27,234 Mln as on 02-Jun-2023. As per Value Research classification, it is a company.

The P/B ratio of Zimmer Biomet Holdings Inc. (ZBH) is 2.20 times as on 02-Jun-2023, a -0.22% premium to its peers’ median range of 2.82 times.

The P/E ratio of Zimmer Biomet Holdings Inc. (ZBH) is 59.55 times as on 02-Jun-2023, a 1.73% premium to its peers’ median range of 21.83 times.

Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Zimmer Biomet Holdings Inc. (ZBH) and enter the required number of quantities and click on buy to purchase the shares of Zimmer Biomet Holdings Inc. (ZBH).

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopaedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

The CEO & director of Mr. Bryan C. Hanson. is Zimmer Biomet Holdings Inc. (ZBH), and CFO & Sr. VP is Mr. Suketu P. Upadhyay.

The promoters of Zimmer Biomet Holdings Inc. (ZBH) have pledged 0% of the total equity as on Mar-23.

Some of the close peers are:

Yes, TTM profit after tax of Zimmer Biomet Holdings Inc. (ZBH) was $450 Mln.